Results 11 to 20 of about 525,855 (266)

Cyclophosphamide in the treatment of focal segmental glomerulosclerosis [PDF]

open access: yesBrazilian Journal of Medical and Biological Research, 2004
Prednisone is the initial treatment of primary focal segmental glomerulosclerosis. However, when immunosuppressive agents in combination with steroids are used in the treatment of prednisone-dependent and prednisone-resistant patients the remission rate ...
R. Martinelli   +4 more
doaj   +5 more sources

Prognostic factors for open globe injuries and correlation of Ocular Trauma Score at a tertiary referral eye care centre in Singapore

open access: yesIndian Journal of Ophthalmology, 2013
Objective: To evaluate the factors influencing final vision outcome after surgical repair of open globe injuries and to correlate the Ocular trauma score.
Rupesh Agrawal, Ho Sue Wei, Stephen Teoh
doaj   +1 more source

Galactose treatment in focal segmental glomerulosclerosis [PDF]

open access: yesPediatric Nephrology, 2013
in their native kidneys and in renal transplants [2, 3]. Preliminary data from the FONT trial (NCT00814255) suggest that some patients treated with oral galactose achieve a significant reduction in proteinuria in parallel with a decline in Palb during 24 weeks of therapy (unpublished observations).
Howard, Trachtman, Virginia J, Savin
openaire   +2 more sources

Treatment of Unicompartmental Cartilage Defects of the Knee with Unicompartmental Knee Arthroplasty, Patellofemoral Partial Knee Arthroplasty or Focal Resurfacing

open access: yesLife, 2021
Focal chondral defects are common lesions of the articular cartilage. They are predominantly found on the medial femoral condyle and often progress to osteoarthritis of the knee. Various conservative treatment options are available.
Bernhard Springer, Friedrich Boettner
doaj   +1 more source

One day wonder: Fast resolution of macular edema following intravitreal ranibizumab in retinal venous occlusions

open access: yesIndian Journal of Ophthalmology, 2013
Macular edema is a significant cause of vision loss in patients with central retinal vein occlusions and branch retinal vein occlusions. Vascular endothelial growth factor (VEGF) appears to be a key factor in the pathogenesis of this disease.
Lalit Verma   +3 more
doaj   +1 more source

Is it possible to predict the treatment efficacy in adult patients with focal epilepsy?

open access: yesЭпилепсия и пароксизмальные состояния, 2020
The aim was to determine the factors impacting the treatment efficacy in patients with focal epilepsy.Materials and methods. This was a prospective, comparative, observational study conducted in real clinical practice.
K. V. Firsov   +2 more
doaj   +1 more source

The role of retinal focal photosensitivity in micropulse treatment of vascular genesis focal macular edema

open access: yesActa Biomedica Scientifica, 2022
Introduction. Vascular macular edema (ME) is the most common in diabetic retinopathy and retinal vein occlusion. To assess the efficacy and safety of ongoing treatment the dynamics of the best-corrected visual acuity is always taken into account, however,
M. Yu. Guro   +2 more
doaj   +1 more source

Galactose treatment in focal and segmental glomerulosclerosis [PDF]

open access: yesPediatric Nephrology, 2014
Sirs,We read with interest the article entitled “Effect of galactoseonglomerularpermeabilityandproteinuriainsteroid-resistantnephrotic syndrome” by Sgambat et al. recently published inPediatricNephrology[1].Inthisprospectiveclinicaltrial,oralgalactose was administered in seven pediatric patients withsteroid-resistant nephrotic syndrome for a 16-week ...
Om P, Mishra, Arun K, Singh
openaire   +2 more sources

Demographic and clinical profile of vernal keratoconjunctivitis at a tertiary eye care center in India

open access: yesIndian Journal of Ophthalmology, 2013
Purpose: To study the demographic and clinical profile of patients with vernal keratoconjunctivitis (VKC) at a tertiary eye care center in India. Materials and Methods: Retrospective chart analysis of 468 patients of VKC seen from January 2006 to ...
Ujwala S Saboo   +3 more
doaj   +1 more source

Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration

open access: yesIndian Journal of Ophthalmology, 2013
Aim: To investigate the role of anti-VEGF monotherapy in patients with thick submacular hemorrhage (SMH) of ≤1 week duration secondary to neovascular age-related macular degeneration (N-AMD). Materials and Methods: A retrospective chart review of 14 eyes
Sachin Jain   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy